<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2025-944
Date of Submission: 2025-07-25

This report was submitted by a Pharmacist from Miller PLC Medical Center concerning patient ANON-PX-5340. The subject is an adult male with a significant medical history including asthma, hypertension, osteoarthritis, migraines. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Lisinopril administered via the Oral route at a dosage of 326mg, initiated on 2025-06-07 for Hypertension and discontinued on 2025-07-13.

On approximately 2025-06-27, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Diarrhea, Anaphylaxis. The Diarrhea was classified as Life-threatening in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Fatal'. The Anaphylaxis was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Thank maintain involve east really political. Nice probably wall get baby star investment computer. With meet idea.</data>
report_id: ADR-2025-944
report_date: '2025-07-25'
patient_details:
  patient_id: ANON-PX-5340
  gender: Male
  relevant_history:
  - asthma
  - hypertension
  - osteoarthritis
  - migraines
suspected_drugs:
- drug_name: Lisinopril
  dosage: 326mg
  route_of_administration: Oral
  start_date: '2025-06-07'
  indication_for_use: Hypertension
  end_date: '2025-07-13'
adverse_reactions:
- symptom_name: Diarrhea
  onset_date: '2025-06-27'
  severity: Life-threatening
  outcome: Fatal
  intervention_required: false
- symptom_name: Anaphylaxis
  onset_date: '2025-06-27'
  severity: Mild
  outcome: Recovering
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Not applicable
reporting_facility: Miller PLC Medical Center
reporter_type: Pharmacist
notes: Thank maintain involve east really political. Nice probably wall get baby star
  investment computer. With meet idea.
